Collegium Pharmaceutical (COLL) Stock Analysis: AI Score & Alternative Data
Demand signals are heating up for Collegium Pharmaceutical
Is Collegium Pharmaceutical a buy right now? The alternative data says hold. This COLL stock analysis is built on the 25+ alternative data signals AltIndex tracks on Collegium Pharmaceutical every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 54/100: a Hold. The stock trades at $22.09 with a $719M market cap.
The data leans positive over the past 90 days — revenue up 5.3% YoY to $200M — but the move hasn’t been broad enough to lift COLL into buy territory yet.
COLL’s broader alt-data profile also covers job postings (21 open roles), headcount (506 employees, according to LinkedIn), web traffic (11K monthly visits), and X followers (97). Every signal links to its own page with full history, the COLL technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on COLL is just below.
Collegium Pharmaceutical AI Stock Analysis
Collegium Pharmaceutical is a specialty pharmaceutical company focused on developing and commercializing innovative abuse-deterrent medications. The company's primary focus is on addressing the opioid crisis by providing safer pain management solutions.
Analysis generated September 30, 2026.
Recent Collegium Pharmaceutical Stock Alerts
|
Collegium Pharmaceutical | August 13 Price is up by 8.6% in the last 24h. |
|
Collegium Pharmaceutical | August 10 Price is down by -6.6% in the last 24h. |
|
Collegium Pharmaceutical | August 6 Price is down by -10.4% in the last 24h. |
Collegium Pharmaceutical Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 11K | N/A | |
| Job Posts | 21 | N/A | |
| LinkedIn Employees | 506 | N/A | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 1 | N/A | |
| Stocktwits Mentions | 0 | N/A | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 2K | N/A | |
| X Followers | 97 | N/A |
About Collegium Pharmaceutical (COLL)
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.
| Price | $22.09 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $719M |
| Year Range | $22 – $50 |
| Dividend Yield | 0% |
| PE Ratio | 17.4 |
| Analyst Rating | 38% buy |
| Industry | Drug Manufacturers |
Latest Collegium Pharmaceutical News
View more → |
Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call TranscriptAugust 13 - Biztoc.com |
 |
COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape GuidanceAugust 9 - Biztoc.com |
Collegium Pharmaceutical Q2 Earnings Call HighlightsAugust 6 - MarketBeat |
|
 |
Chronic Pain Market Poised for Growth at a CAGR of 5% During the Forecast Period (2026-2036), as Rising Patient Burden and Novel Treatment Approaches are Creating New Opportunities | DelveInsightSeptember 22 - PRNewswire |
See Collegium Pharmaceutical’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for COLL, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREECollegium Pharmaceutical Earnings & Financial Performance
View all earnings →Collegium Pharmaceutical Insider Trading Activity
View all →| Freund John Gordon filed to sell 83,952 shares at $0.0. May 18 '26 |
| Freund John Gordon filed to sell 83,972 shares at $0.0. May 15 '26 |
| Lurker Nancy filed to sell 18,017 shares at $0.0. May 13 '26 |
| BOHLIN GAREN G filed to sell 62,259 shares at $0.0. May 11 '26 |
| Dieter David filed to sell 77,071 shares at $0.0. Mar 18 '26 |
Collegium Pharmaceutical Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Collegium Pharmaceutical
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Esperion TherapeuticsESPR |
$3.18 0.3% | $819M | 45 |
 |
Aquestive TherapeuticsAQST |
$4.78 0.4% | $600M | 43 |
 |
EvotecEVO |
$1.53 2.6% | $544M | 31 |
 |
EvolusEOLS |
$7.73 0.9% | $511M | 48 |
 |
Lifecore BiomedicalLFCR |
$6.45 0.3% | $244M | 41 |
Explore Collegium Pharmaceutical Data
Frequently Asked Questions: Collegium Pharmaceutical (COLL)
Collegium Pharmaceutical has an AltIndex AI Score of 54/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
54/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Collegium Pharmaceutical (COLL) stock is $22.09 with a market cap of $719M.
As of today, Collegium Pharmaceutical’s PE (Price to Earnings) ratio is 17.4.
View the latest Collegium Pharmaceutical insider transactions to see recent buying and selling activity by company executives and directors.
Check the Collegium Pharmaceutical congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The COLL stock price chart above shows Collegium Pharmaceutical’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Collegium Pharmaceutical technical analysis for RSI, moving averages, and more.
See the stocks similar to Collegium Pharmaceutical section on this page for companies in the same industry ranked by market cap and AI Score.
